在工程化介质干细胞外体中取得的进展,用于治疗慢性肺病
Zhengyao Zhai1, Tairong Cui1, Jialiang Chen1
1The First School of Medicine, School of Information and Engineering, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Journal of translational medicine
|December 9, 2023
概括
工程化介质干细胞外体 (MSC-exos) 显示出治疗慢性肺部疾病的前景. 这些修改后的外体提供了增强的药物输送和呼吸道疾病的治疗效果.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 肺部病理学 肺部病理学
背景情况:
- 慢性肺部疾病带来了重大的健康挑战.
- 介质细胞干细胞 (MSC) 和它们的外体细胞 (MSC-exos) 由于抗炎和免疫调节性质,具有治疗潜力.
- 目前,慢性肺病的治疗方法有限.
研究的目的:
- 审查工程MSC-exos治疗慢性呼吸道疾病的策略和机制.
- 探索工程MSC-exos的增强能力,包括有针对性的药物输送和障碍穿越.
- 提供对慢性肺部疾病的新型治疗解决方案的见解.
主要方法:
- 对工程MSC-exos在慢性肺病治疗中的现有研究进行审查.
- 对MSC-exos.应用的各种工程修改的分析.
- 检查工程MSC-exos. 的生物效应和治疗结果.
主要成果:
- 工程MSC-exos证明了药物递送和向效率的增强.
- 这些外体可以穿越生理障碍,到达患病的肺组织.
- 不同的工程策略为治疗结果产生特定的生物效应.
结论:
- 工程MSC-exos是慢性肺部疾病的有前途的治疗剂.
- 它们克服生物障碍并有效提供治疗药物的能力是关键.
- 对工程MSC-exos的进一步研究为治疗呼吸系统疾病提供了新的途径.
更多相关视频
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


